Jeremy Farrar

Born in Singapore, Farrar is the youngest of six children in his family. His father taught English and his mother was a writer and artist. Due to his father's work, he spent his childhood in New Zealand, Cyprus and Libya.James Ashton (18 January 2015), [https://www.independent.co.uk/news/science/jeremy-farrar-interview-wellcome-trust-director-says-im-not-a-great-believer-in-the-power-of-prayer-9986626.html Jeremy Farrar interview: Wellcome Trust director says 'I'm not a great believer in the power of prayer'] The Independent.

Farrar was educated at Churcher's College{{cite news |url =https://www.theguardian.com/tv-and-radio/2020/dec/06/covid-scientist-jeremy-farrar-had-recurring-nightmare-about-failing-a-levels|newspaper =The Guardian |title =Covid scientist Jeremy Farrar had recurring nightmare about failing A-levels|first =Nosheen|last =Iqbal |date =6 December 2020 }} and UCL Medical School,[http://www.bbc.co.uk/programmes/b0496c03 Jeremy Farrar Interviewed by Jim Al-Khalili] on The Life Scientific, 14 July 2014 from where he obtained a Bachelor of Science degree in immunology in 1983 and a Bachelor of Medicine, Bachelor of Surgery degree in 1986.{{cite web|url=http://www.antimicrobe.org/authors/jeremy_farrar.asp|title=Jeremy Farrar|website=antimicrobe.org}} Farrar completed his Doctor of Philosophy degree at the University of Oxford in 1998 on myasthenia gravis.{{cite thesis |degree=DPhil |first=Jeremy|last=Farrar |title=Analysis of combinatorial immunoglobin libraries from a myasthenia gravis patient |publisher=University of Oxford |year=1997 |url=http://solo.bodleian.ox.ac.uk/OXVU1:LSCOP_OX:oxfaleph012767801|id={{EThOS|uk.bl.ethos.339366}}|author-link=Jeremy Farrar}}

Farrar's research interests are in infectious diseases such as tuberculosis,{{Cite journal | last1 = Thwaites | first1 = G. E. | last2 = Nguyen | first2 = N. D. | last3 = Nguyen | first3 = N. H. | last4 = Hoang | first4 = H. T. | last5 = Do | first5 = D. T. T. | last6 = Nguyen | first6 = N. T. C. | last7 = Nguyen | first7 = N. Q. | last8 = Nguyen | first8 = N. T. | last9 = Nguyen | first9 = N. N. | last10 = Nguyen | doi = 10.1056/NEJMoa040573 | first10 = N. T. N. | last11 = Nguyen | first11 = N. N. | last12 = Nguyen | first12 = N. H. | last13 = Vu | first13 = V. N. | last14 = Cao | first14 = C. H. | last15 = Tran | first15 = T. T. H. | last16 = Pham | first16 = P. P. | last17 = Nguyen | first17 = N. T. | last18 = Stepniewska | first18 = K. | last19 = White | first19 = N. J. | last20 = Tran | first20 = T. T. | last21 = Farrar | first21 = J. J. | title = Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults | journal = New England Journal of Medicine | volume = 351 | issue = 17 | pages = 1741–1751 | year = 2004 | pmid = 15496623| doi-access = free }} dengue fever,{{Cite journal | doi = 10.1186/1471-2334-10-142| pmid = 20509940| title = Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses| journal = BMC Infectious Diseases| volume = 10| pages = 142| year = 2010| last1 = Tricou | first1 = V. | last2 = Vu | first2 = H. T. | last3 = Quynh | first3 = N. V. | last4 = Nguyen | first4 = C. V. | last5 = Tran | first5 = H. T. | last6 = Farrar | first6 = J. | last7 = Wills | first7 = B. | last8 = Simmons | first8 = C. P. | pmc = 2895602| doi-access = free}}{{Cite journal | last1 = Guzman | first1 = M. G. | last2 = Halstead | first2 = S. B. | last3 = Artsob | first3 = H. | last4 = Buchy | first4 = P. | last5 = Farrar | first5 = J. | last6 = Gubler | first6 = D. J. | last7 = Hunsperger | first7 = E. | last8 = Kroeger | first8 = A. | last9 = Margolis | first9 = H. S. | doi = 10.1038/nrmicro2460 | last10 = Martínez | first10 = E. | last11 = Nathan | first11 = M. B. | last12 = Pelegrino | first12 = J. L. | last13 = Simmons | first13 = C. | last14 = Yoksan | first14 = S. | last15 = Peeling | first15 = R. W. | title = Dengue: A continuing global threat | journal = Nature Reviews Microbiology | volume = 8 | issue = 12 | pages = S7–16 | year = 2010 | pmid = 21079655 | pmc = 4333201}}{{Cite journal | doi = 10.1056/NEJMoa044057| pmid = 16135832| title = Comparison of Three Fluid Solutions for Resuscitation in Dengue Shock Syndrome| journal = New England Journal of Medicine| volume = 353| issue = 9| pages = 877–89| year = 2005| last1 = Wills | first1 = B. A. | last2 = Dung | first2 = N. M. | last3 = Loan | first3 = H. T. | last4 = Tam | first4 = D. T. H. | last5 = Thuy | first5 = T. T. N. | last6 = Minh | first6 = L. T. T. | last7 = Diet | first7 = T. V. | last8 = Hao | first8 = N. T. | last9 = Chau | first9 = N. V. | last10 = Stepniewska | first10 = K. | last11 = White | first11 = N. J. | last12 = Farrar | first12 = J. J. | s2cid = 30791461| doi-access = free }}{{Cite journal

| last1 = Solomon | first1 = T.

| last2 = Dung | first2 = N. M.

| last3 = Vaughn | first3 = D. W.

| last4 = Kneen | first4 = R.

| last5 = Thao | first5 = L. T. T.

| last6 = Raengsakulrach | first6 = B.

| last7 = Loan | first7 = H. T.

| last8 = Day | first8 = N. P.

| last9 = Farrar | first9 = J.

| last10 = Myint

| doi = 10.1016/S0140-6736(00)02036-5 | first10 = K. S.

| last11 = Warrell | first11 = M. J.

| last12 = James | first12 = W. S.

| last13 = Nisalak | first13 = A.

| last14 = White | first14 = N. J.

| title = Neurological manifestations of dengue infection

| journal = The Lancet

| volume = 355

| issue = 9209

| pages = 1053–1059

| year = 2000

| pmid = 10744091

| s2cid = 21731410

}} typhoid fever, malaria, and H5N1 influenza.{{Cite journal | doi = 10.1038/509555a| pmid = 24877180| title = Policy: An intergovernmental panel on antimicrobial resistance| journal = Nature| volume = 509| issue = 7502| pages = 555–7| year = 2014| last1 = Woolhouse | first1 = Mark| last2 = Farrar | first2 = Jeremy| author-link2 = Jeremy Farrar| doi-access = free}}{{Cite journal | last1 = Farrar | first1 = J. | author-link = Jeremy Farrar| title = H5N1 surveillance: Shift expertise to where it matters | doi = 10.1038/483534a | journal = Nature | volume = 483 | issue = 7391 | pages = 534–535 | year = 2012 | pmid = 22460881| pmc = 7095293 | bibcode = 2012Natur.483..534F | doi-access = free }}{{Cite journal

| last1 = Hien | first1 = T. T.

| last2 = Nguyen | first2 = N. T.

| last3 = Nguyen | first3 = N. T.

| last4 = Luong | first4 = L. T.

| last5 = Pham | first5 = P. P.

| last6 = Nguyen | first6 = N. V. V.

| last7 = Pham | first7 = P. T.

| last8 = Vo | first8 = V. C.

| last9 = Le | first9 = L. T. Q.

| last10 = Ngo

| doi = 10.1056/NEJMoa040419 | first10 = N. T.

| last11 = Dao | first11 = D. B.

| last12 = Le | first12 = L. P.

| last13 = Nguyen | first13 = N. T.

| last14 = Hoang | first14 = H. T.

| last15 = Cao | first15 = C. V.

| last16 = Le | first16 = L. T.

| last17 = Nguyen | first17 = N. D.

| last18 = Le | first18 = L. H.

| last19 = Nguyen | first19 = N. T. K.

| last20 = Le | first20 = L. H.

| last21 = Le | first21 = L. V.

| last22 = Christiane | first22 = C.

| last23 = Tran | first23 = T. T.

| last24 = Menno De | first24 = M.

| last25 = Schultsz | first25 = C.

| last26 = Cheng | first26 = P.

| last27 = Lim | first27 = W.

| last28 = Horby | first28 = P.

| last29 = Farrar | first29 = J.

| author30 = World Health Organization International Avian Influenza Investigative Team

| title = Avian Influenza A (H5N1) in 10 Patients in Vietnam

| journal = New England Journal of Medicine

| volume = 350

| issue = 12

| pages = 1179–1188

| year = 2004

| pmid = 14985470

| doi-access = free

}}{{Cite journal

| last1 = De Jong | first1 = M. D.

| last2 = Simmons | first2 = C. P.

| last3 = Thanh | first3 = T. T.

| last4 = Hien | first4 = V. M.

| last5 = Smith | first5 = G. J. D.

| last6 = Chau | first6 = T. N. B.

| last7 = Hoang | first7 = D. M.

| last8 = Chau | first8 = N.

| last9 = Khanh | first9 = T. H.

| last10 = Dong

| doi = 10.1038/nm1477 | first10 = V. C.

| last11 = Qui | first11 = P. T.

| last12 = Cam | first12 = B.

| last13 = Ha Do | first13 = D. Q.

| last14 = Guan | first14 = Y.

| last15 = Peiris | first15 = J. S. M.

| last16 = Chinh | first16 = N. T.

| last17 = Hien | first17 = T. T.

| last18 = Farrar | first18 = J.

| title = Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia

| journal = Nature Medicine

| volume = 12

| issue = 10

| pages = 1203–1207

| year = 2006

| pmid = 16964257

| pmc = 4333202}}

From 1996 until 2013, Farrar was Director of the Oxford University Clinical Research Unit in Ho Chi Minh City.{{Cite journal|doi= 10.1016/S0140-6736(13)62047-4|title = Jeremy Farrar: Wellcome arrival from southeast Asia|journal = The Lancet|volume = 382|issue = 9899|pages = 1167|year = 2013|last1 = Watts|first1 = Geoff|pmid=24095187|s2cid = 205970840}}{{YouTube|id=x-RSAr2xnMA|title=Jeremy Farrar on Connecting your research with society}}{{YouTube|id=UzvPeYFA8WI|title=Exchanges at the Frontier: Jeremy Farrar}} In 2004, he and his Vietnamese colleague Tran Tinh Hien identified the re-emergence of the deadly bird flu, or H5N1, in humans.Annie Maccoby Berglof (20 June 2014), [https://www.ft.com/content/e6e8b13a-f2df-11e3-a3f8-00144feabdc0 At Home with the FT House & Home: Wellcome Trust director Jeremy Farrar] Financial Times.{{YouTube|id=UHCtj59N7LM|title=Jeremy Farrar seeks innovative backgrounds to help fight infectious diseases, Wired UK}} He was Professor of Tropical Medicine and Global Health at the University of Oxford from 2000 until 2013.

In addition to his academic work, Farrar was part of the Center for Global Development’s Working Group on Priority-Setting Institutions for Global Health in 2012.[https://www.cgdev.org/working-group/priority-setting-institutions-global-health Working Group on Priority-Setting Institutions for Global Health] Center for Global Development (CGD).

In 2013, Farrar was appointed Director of the Wellcome Trust. During his time at the Wellcome Trust, with Chris Whitty and Neil Ferguson, he co-authored an article in Nature titled "Infectious disease: Tough choices to reduce Ebola transmission",{{cite journal |doi=10.1038/515192a|title=Infectious disease: Tough choices to reduce Ebola transmission|year=2014|last1=Whitty|first1=Christopher J. M.|author-link1=Chris Whitty|last2=Farrar|first2=Jeremy|author-link2=Jeremy Farrar|last3=Ferguson|first3=Neil|author-link3=Neil Ferguson (epidemiologist)|last4=Edmunds|first4=W. John|last5=Piot|first5=Peter|last6=Leach|first6=Melissa|last7=Davies|first7=Sally C.|journal=Nature|volume=515|issue=7526|pages=192–194|pmid=25391946|bibcode=2014Natur.515..192W|doi-access=free}} explaining the UK government's response to Ebola in Sierra Leone, including the proposal to build and support centres where people could self-isolate voluntarily if they suspected that they could have the disease.{{Cite web|url=http://www.ebola-anthropology.net/key_messages/infectious-disease-tough-choices-to-reduce-ebola-transmission/|title=Infectious disease: Tough choices to reduce Ebola transmission {{!}} Ebola Response Anthropology Platform|website=www.ebola-anthropology.net|access-date=10 March 2020}} In July 2015, he co-authored a paper in The New England Journal of Medicine (with Adel Mahmoud and Stanley A. Plotkin), titled "Establishing a Global Vaccine-Development Fund", that led to the founding in 2017 of the Coalition for Epidemic Preparedness Innovations (CEPI).{{cite journal|author=Jon Cohen|date=2 September 2016|title=New vaccine coalition aims to ward off epidemics|url=https://www.science.org/content/article/new-vaccine-coalition-aims-ward-epidemics|journal=Science|volume=353|issue=6303}}{{cite journal | title=Establishing a Global Vaccine-Development Fund | journal=The New England Journal of Medicine | date=23 July 2015 | author1=Stanley A. Plotkin | author2= Adel A.F. Mahmoud | author3=Jeremy Farrar | doi= 10.1056/NEJMp1506820 |pmid = 26200974| pages=297–300 | volume=373|issue = 4| doi-access=free }} Together with a number of others, in 2016 he proposed a World Serum Bank as a means of helping combat epidemics.{{cite journal |doi=10.1016/S0140-6736(16)30164-7|title=Use of serological surveys to generate key insights into the changing global landscape of infectious disease|year=2016|last1=Metcalf|first1=C Jessica E.|last2=Farrar|first2=Jeremy|author-link2=Jeremy Farrar|last3=Cutts|first3=Felicity T.|last4=Basta|first4=Nicole E.|last5=Graham|first5=Andrea L.|author-link5=Andrea L. Graham|last6=Lessler|first6=Justin|last7=Ferguson|first7=Neil M.|author-link7=Neil Ferguson (epidemiologist)|last8=Burke|first8=Donald S.|author-link8=Donald Burke|last9=Grenfell|first9=Bryan T.|author-link9=Bryan Grenfell|journal=The Lancet|volume=388|issue=10045|pages=728–730|pmid=27059886|pmc=5678936}}

In addition to his role at the Wellcome Trust, Farrar has served as chair on several advisory boards for governments and global organizations. In 2017, he was part of the selection committee chaired by Jules A. Hoffmann that chose Stewart Cole as director of the Institut Pasteur.[https://www.pasteur.fr/en/research-journal/news/launch-recruitment-process-director-institut-pasteur Launch of the recruitment process for the Director of the Institut Pasteur] Institut Pasteur, press release of 2 May 2017. From 2017 until 2019, he was a member of the German Ministry of Health’s International Advisory Board on Global Health, chaired by Ilona Kickbusch.[https://www.bundesgesundheitsministerium.de/english-version/press/2018/international-advisory-board.html Four new members complete the International Advisory Board on Global Health] Federal Ministry of Health, press release of July 2, 2018. In 2019 he served on The Lancet Commission on Tuberculosis, co-chaired by Eric Goosby, Dean Jamison and Soumya Swaminathan.[http://buildatbfreeworld.org/about-us/commissioners Commissioners] The Lancet Commission on TB. He is also a member of the Health and Biomedical Sciences International Advisory Council (HBMS IAC) at the Agency for Science, Technology and Research of Singapore.[https://www.a-star.edu.sg/About-A-STAR/biomedical-research-council/health-and-biomedical-sciences-international-advisory-council Health and Biomedical Sciences International Advisory Council (HBMS IAC)] Agency for Science, Technology and Research of Singapore.

In 2020, he was appointed to the Global Leaders Group on Antimicrobial Resistance, co-chaired by Sheikh Hasina and Mia Mottley.[https://www.who.int/groups/one-health-global-leaders-group-on-antimicrobial-resistance Global Leaders Group on Antimicrobial Resistance] World Health Organization. In the preparations for the Global Health Summit hosted by the European Commission and the G20 in May 2021, he was a member of the event's High Level Scientific Panel.[https://global-health-summit.europa.eu/panel-scientific-experts_en Global Health Summit: Panel of Scientific Experts] European Commission.

Farrar has served on a number of WHO committees, co-chairing the World Health Organization’s working group on dengue vaccines from 2015 until 2016.[https://web.archive.org/web/20150525022955/http://www.who.int/immunization/policy/sage/sage_wg_dengue_mar2015/en/ SAGE Working Group on Dengue Vaccines and Vaccination (March 2015 to August 2016)] World Health Organization.Julie Steenhuysen and Ben Hirschler (13 December 2017), [https://www.reuters.com/article/us-sanofi-dengue-science-insight/did-sanofi-who-ignore-warning-signals-on-dengue-vaccine-idUSKBN1E7072 Did Sanofi, WHO ignore warning signals on dengue vaccine?] Reuters. Since its inception in 2017, Farrar has been chairing the Scientific Advisory Group of the WHO R&D Blueprint, a global strategy and preparedness plan that allows the rapid activation of research activities during epidemics.[https://www.who.int/blueprint/about/sag-members/en/ R&D Blueprint Scientific Advisory Group members] World Health Organization. From 2018 to 2022, he served on the joint World Bank/WHO Global Preparedness Monitoring Board (GPMB), co-chaired by Elhadj As Sy and Gro Harlem Brundtland.[http://www.worldbank.org/en/news/press-release/2018/05/24/who-and-world-bank-group-join-forces-to-strengthen-global-health-security WHO and World Bank Group Join Forces to Strengthen Global Health Security] World Bank, press release of 24 May 2018.[https://www.gpmb.org/news/news/item/30-09-2022-global-preparedness-monitoring-board-announces-new-board-membership-bringing-diverse-expertise-to-independent-monitoring Global Preparedness Monitoring Board Announces New Board Membership, Bringing Diverse Expertise to Independent Monitoring] World Bank/WHO Global Preparedness Monitoring Board (GPMB), press release of 30 September 2022. In 2019, he co-chaired a WHO committee evaluating Ebola therapeutics.Donald G. McNeil Jr. (12 August 2019), [https://www.nytimes.com/2019/08/12/health/ebola-outbreak-cure.html A Cure for Ebola? Two New Treatments Prove Highly Effective in Congo] The New York Times.Sarah Boseley (August 12, 2019), [https://www.theguardian.com/world/2019/aug/12/ebola-now-curable-after-trials-of-drugs-in-drc-say-scientists Ebola now curable after trials of drugs in DRC, say scientists] The Guardian.

Farrar has also served on UK governments committees. In May 2020, amid the COVID-19 pandemic, he was appointed to the expert advisory group for the UK Government’s Vaccine Task Force. He has also served as a member of the UK Scientific Advisory Group for Emergencies (SAGE), led by Patrick VallanceMark Landler and Stephen Castle (April 23, 2020), [https://www.nytimes.com/2020/04/23/world/europe/uk-coronavirus-sage-secret.html The Secretive Group Guiding the U.K. on Coronavirus] New York Times. (up to 2 November 2021, when Farrar resigned in disagreement with the government's approach), and Public Health England’s Serology Working Group.[https://www.gov.uk/government/publications/scientific-advisory-group-for-emergencies-sage-coronavirus-covid-19-response-membership/list-of-participants-of-sage-and-related-sub-groups List of participants of SAGE and related sub-groups, 7 May 2020] Government of the United Kingdom. During Farrar's time in SAGE, Health Secretary Matt Hancock sought to have him removed from the group following his criticisms of the government's handling of Covid, the abolition of Public Health England (PHE) and the appointment of Dido Harding to head the ineffective and expensive Test and Trace programme.{{cite web | last=Campbell | first=Denis | title=Matt Hancock plotted to oust NHS England chief, WhatsApp leak shows | website=the Guardian | date=5 March 2023 | url=https://www.theguardian.com/politics/2023/mar/05/hancock-plotted-to-oust-nhs-england-chief-simon-stevens-whatsapp-leak-shows | access-date=5 March 2023}}

[https://www.gov.uk/government/news/funding-and-manufacturing-boost-for-uk-vaccine-programme Funding and manufacturing boost for UK vaccine programme] Government of the United Kingdom, press release of May 17, 2020. In July 2021 he published the book Spike: The Virus vs The People, co-authored with Financial Times journalist Anjana Ahuja, giving his account of the UK government's response to the Covid-19 pandemic.{{cite web| url = https://www.scotsman.com/arts-and-culture/books/book-review-spike-the-virus-vs-the-people-by-sir-jeremy-farrar-and-anjana-ahuja-3318864| title = Book review: Spike - The Virus vs the People, by Sir Jeremy Farrar and Anjana Ahuja {{!}} The Scotsman| date = 22 July 2021}}

Farrar was listed in Time's 2024 most influential people in health list.{{Cite magazine |last=Ducharme |first=Jamie |date=2024-05-02 |title=Jeremy Farrar |url=https://time.com/6963684/jeremy-farrar/ |access-date=2024-09-17 |magazine=TIME |language=en}}

On 19 February 2020, Farrar, along with 26 other scientists, published a letter in The Lancet titled "Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19'" in which the authors declared, "We stand together to strongly condemn conspiracy theories suggesting that COVID-19 does not have a natural origin."{{Cite journal |last1=Calisher |first1=Charles |last2=Carroll |first2=Dennis |last3=Colwell |first3=Rita |last4=Corley |first4=Ronald B |last5=Daszak |first5=Peter |last6=Drosten |first6=Christian |last7=Enjuanes |first7=Luis |last8=Farrar |first8=Jeremy |last9=Field |first9=Hume |last10=Golding |first10=Josie |last11=Gorbalenya |first11=Alexander |last12=Haagmans |first12=Bart |last13=Hughes |first13=James M |last14=Karesh |first14=William B |last15=Keusch |first15=Gerald T |date=2020-02-19 |title=Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19 |url=https://doi.org/10.1016/S0140-6736(20)30418-9 |journal=The Lancet |volume=395 |issue=10226 |pages=e42–e43 |doi=10.1016/s0140-6736(20)30418-9 |issn=0140-6736 |pmc=7159294 |pmid=32087122}} No conflict of interest[https://usrtk.org/covid-19-origins/who-top-scientist-farrar-was-collaborator-of-peter-daszak WHO top scientist was ‘collaborator’ of Peter Daszak] U.S. Right To Know was reported.

Farrar wrote an opinion piece in the Guardian on Dec. 4, 2021 stating he feared not enough was being done to vaccinate people in poor nations against COVID-19. Farrar stated, “The longer this virus continues to spread in largely unvaccinated populations globally, the more likely it is that a variant that can overcome our vaccines and treatments will emerge. If that happens, we could be close to square one. This political drift and lack of leadership is prolonging the pandemic for everyone, with governments unwilling to really address inequitable access to the vaccines, tests and treatment. There have been wonderful speeches, warm words, but not the actions needed to ensure fair access to what we know works and would bring the pandemic to a close.”[https://www.theguardian.com/world/2021/dec/04/uks-progress-on-covid-now-squandered-warns-top-scientist UK’s progress on Covid now squandered, warns top scientist] The Guardian

• Temasek Holdings, Member of the International Panel[https://www.temasekreview.com.sg/steward/sharing-perspectives.html Temasek Review 2019: Temasek International Panel] Temasek Holdings.

• National Academy of Sciences (NAS), Member of the Climate & Health Initiative Planning Committee (since 2020)[https://nam.edu/programs/climate-change-and-human-health/climate-change-advisory-committee/ Climate & Health Initiative Planning Committee] National Academy of Sciences (NAS).
• Geneva Science and Diplomacy Anticipator (GESDA), Member of the Board of Directors (since 2020)[https://gesda.global/who-we-are/ Who we are] Geneva Science and Diplomacy Anticipator (GESDA).
• Genome Research Limited, Chairman of the Board (since 2020)[https://www.sanger.ac.uk/news/view/appointments-and-changes-genome-research-limited-board Appointments and changes to the Genome Research Limited Board] Wellcome Trust Sanger Institute, press release of 9 December 2019.
• Global Health Innovative Technology Fund (GHIT), Member of the Council (since 2018)[https://www.ghitfund.org/newsroom/news/detail/221/en GHIT Fund Announces New Council Member Jeremy Farrar] Global Health Innovative Technology Fund (GHIT Fund), press release of 8 August 2018.
• Coalition for Epidemic Preparedness Innovations (CEPI), Member of the Board and Co-Founder (since 2017){{cite news | url=https://www.ft.com/content/5699ac84-dd87-11e6-86ac-f253db7791c6 | title=Davos launch for coalition to prevent epidemics of emerging viruses | newspaper=Financial Times | author=Clive Cookson | date=18 January 2017 | access-date=6 March 2020 | quote=Billion-dollar programme aims to cut vaccine-development time from 12 years to one}}
• Global He@lth 2030 Innovation Task Force, Member of the Advisory Council (since 2015)[http://www.globalhealth2030.org/cochairs About Us] Global He@lth 2030 Innovation Task Force.
• Global Alliance for Genomics and Health (GA4GH), Member of the Strategic Advisory Board (since 2013)[https://www.ga4gh.org/aboutus/strategic-advisory-board/ Strategic Advisory Board] Global Alliance for Genomics and Health (GA4GH).
• Aga Khan University, Member of the Board of Trustees[https://www.aku.edu/about/trustees/Pages/home.aspx Board of Trustess] Aga Khan University.
• Forward Institute, Advisor[https://www.forward.institute/advisors-senior-sponsors Advisory Board & Senior Sponsors] Forward Institute.
• Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), Vice-Chair[https://www.glopid-r.org/governance/ Governance]Global Research Collaboration for Infectious Disease Preparedness (GloPID-R).
• Francis Crick Institute, Member of the Board[https://www.crick.ac.uk/about-us/leadership-structure/board/jeremy-farrar Jeremy Farrar] Francis Crick Institute.
• Office for Strategic Coordination of Health Research (OSCHR), Member of the Board[https://www.cso.scot.nhs.uk/funding-2/office-for-strategic-coordination-of-health-research-oschr/ Office for Strategic Coordination of Health Research (OSCHR)] National Health Service.
• The New England Journal of Medicine, Member of the Editorial Board[https://www.nejm.org/about-nejm/editors-and-publishers Editors and Publishers] The New England Journal of Medicine.
• Patan Academy of Health Sciences (PAHS), Member of the International Advisory Board[https://www.pahs.edu.np/pahs-community/international-advisory-board/ International Advisory Board] Patan Academy of Health Sciences (PAHS).
• UK Collaborative on Development Research (UKCDR), Member of the Strategic Coherence of ODA-funded Research[https://www.ukcdr.org.uk/about-us/our-governance/ Strategic Coherence of ODA-funded Research] {{Webarchive|url=https://web.archive.org/web/20200511113055/https://www.ukcdr.org.uk/about-us/our-governance/ |date=11 May 2020 }} UK Collaborative on Development Research (UKCDR).
• Vanke School of Public Health at Tsinghua University, Member of the International Advisory Board[https://vsph.tsinghua.edu.cn/en/gywm/International_Advisory_Board.htm Vanke School of Public Health: International Advisory Board] Tsinghua University.
• WHO Collaborating Centre for Modelling, Evolution and Control of Emerging Infectious Diseases, University of Cambridge, Member of the Advisory Board[https://www.whocc.infectiousdisease.cam.ac.uk/directory#10 Advisory Board] WHO Collaborating Centre for Modelling, Evolution and Control of Emerging Infectious Diseases, University of Cambridge.
• WomenLift Health, Member of the Global Advisory Board[https://www.womenlifthealth.org/global-advisory-board Global Advisory Board] WomenLift Health.
• Global Leaders Group on Antimicrobial Resistance, Member (since 2020){{Cite web|title=Global Leaders Group for antimicrobial resistance- Members|url=https://www.amrleaders.org/general/members|access-date=2022-01-17|website=www.amrleaders.org|language=en|archive-date=15 December 2021|archive-url=https://web.archive.org/web/20211215152020/https://www.amrleaders.org/general/members|url-status=dead}}

Farrar is a member of the Royal College of Physicians and a Fellow of the Academy of Medical Sciences. He was appointed Officer of the Order of the British Empire in the 2005 New Year Honours for services to healthcare, especially the prevention of tropical diseases, in Vietnam.{{London Gazette |issue=57509 |date=31 December 2004 |page=24 |supp=y}} His citation on election to the Academy of Medical Sciences reads:{{cite web|url=http://www.acmedsci.ac.uk/fellows/fellows-directory/ordinary-fellows/professor-jeremy-farrar/ |title=Dr Jeremy Farrar OBE FMedSci |publisher=Academy of Medical Sciences |archive-date=22 December 2015 |archive-url=https://web.archive.org/web/20151222114251/http://www.acmedsci.ac.uk/fellows/fellows-directory/ordinary-fellows/professor-jeremy-farrar/ |location=London |url-status=dead }}

{{blockquote|Jeremy Farrar is director of the Wellcome Trust-funded Oxford University Clinical Research Unit. Over the past ten years he has created a remarkable research institute in which his own research productivity has been phenomenal and an impressive training program has been developed. Under his direction the research programme has conducted seminal work on malaria, dengue, typhoid, tetanus, pyogenic and tuberculous meningitis and has become the leading centre for clinical research on avian influenza. These Pivotal clinical and virological studies have identified the dual importance of viral burden and the cytokine response to the lethal pathogenesis of avian influenza, and have described the rapid emergence of resistance to neuraminidase inhibitors. The unit has also conducted important research into Dengue shock syndrome, conducting the only large prospective randomised trials of fluid replacement and has provided an evidence-base for revision of the World Health Organisation classification. His commitment to fighting emerging infectious diseases at their source in developing countries is commendable and his contribution to capacity building in Vietnam and other countries is vital for the future of health care in these regions and serves as a model for others to follow.}}

Farrar was elected a Fellow of the Royal Society in 2015.{{cite web|archive-url=https://web.archive.org/web/20151117101151/https://royalsociety.org/people/jeremy-farrar-11423/|archive-date=17 November 2015|url=https://royalsociety.org/people/jeremy-farrar-11423/|title=Professor Jeremy Farrar OBE FMedSci FRS|publisher=Royal Society|location=London}} He was appointed a Knight Bachelor in the 2019 New Year Honours for services to Global Health.{{London Gazette |issue=62507 |date=29 December 2018 |page=N2 |supp=y}}

Farrar has been married to Christiane Dolecek, an Austrian-born typhoid researcher, since 1998. They have three children and live in Oxford. Since 2011, the family {{cite web|url=https://www.farrarfoundation.org|website=farrarfoundation.org|title= Farrar Foundation}} has focused on providing educational assistance to youth from Vietnam and Nepal.Katrin Elger and Veronika Hackenbroch (8 December 2014), [https://www.spiegel.de/international/world/infectious-disease-expert-jeremy-farrar-on-ebola-epidemic-a-1006019.html Epidemics Expert Jeremy Farrar: 'The Most Dangerous Emerging Disease Is Drug Resistance'] Der Spiegel.

{{Reflist}}

{{Authority control}}

{{s-start}}

{{s-culture}}

{{s-bef | before = Mark Walport}}

{{s-ttl | title = Director of the Wellcome Trust

| years = 2013 – date}}

{{s-inc}}

|-

{{s-end}}

{{Wellcome Trust}}

{{Francis Crick Institute}}

{{FRS 2015}}

{{DEFAULTSORT:Farrar, Jeremy}}

Category:Living people

Category:Wellcome Trust

Category:Officers of the Order of the British Empire

Category:Fellows of the Academy of Medical Sciences (United Kingdom)

Category:Knights Bachelor

Category:Fellows of the Royal Society

Category:1961 births

Category:People educated at Churcher's College

Category:Members of the National Academy of Medicine